Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
Mandates drive collection of sexual orientation and gender identity data in oncology clinics
In a multi-institutional qualitative study recently published in JAMA Network Open, U.S. researchers sought to…
Why don’t bats get cancer?
A study to look at why long-lived bats do not get cancer has broken new…
Racial differences in tumour collagen structure may impact cancer prognosis
In cancer care, accurate tools for predicting whether a tumour will metastasise can help patients…
Patients are opting in for 10 years of breast cancer treatment
- ASKHER2 European survey shows perceived risk and fear of disease recurrence affect health behaviours and decision-making in women with early-stage HER2+ breast cancer
- Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts
- ASCO 2025: Vepdegestrant could extend progression-free survival for some people with ESR1-mutated advanced breast cancer
New gene-editing therapy shows early success in advanced GI cancers
- Cancer Council Victoria’s statewide Bowel Screening Campaign results
- SALSA: A new artificial intelligence tool for the automated and precise analysis of liver tumours
- AACR 2025: A topical BRAF-inhibiting gel may mitigate acneiform rash in patients receiving EGFR-targeted therapy for colorectal cancer
ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide
In a collaboration announced today, the American Society of Clinical Oncology, Inc.(ASCO) will work with the World Health Organization (WHO)…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.